NEKTAR THERAPEUTICS Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Nektar Therapeutics quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Nektar Therapeutics Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $9K.
  • Nektar Therapeutics Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$9K, a 100% decline year-over-year.
  • Nektar Therapeutics annual Income Tax Expense (Benefit) for 2023 was -$200K, a 106% decline from 2022.
  • Nektar Therapeutics annual Income Tax Expense (Benefit) for 2022 was $3.22M, a 477% increase from 2021.
  • Nektar Therapeutics annual Income Tax Expense (Benefit) for 2021 was $557K, a 13% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9K $9K +$70K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$79K $46K +$93K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$172K -$35K +$28K +44.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$200K -$29K -$3.17M -101% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $2.97M -$61K +$94K +60.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $2.88M -$47K -$147K -147% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $3.03M -$63K -$189K -150% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $3.22M $3.14M +$3.15M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $67K -$155K -$267K -238% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $334K $100K -$257K -72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $591K $126K +$34K +37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $557K -$4K -$132K -103% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $689K $112K +$91K +433% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $598K $357K +$213K +148% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $385K $92K -$108K -54% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $493K $128K -$150K -54% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $643K $21K -$78K -78.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $721K $144K +$45K +45.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $676K $200K +$63K +46% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $613K $278K +$2.12M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$1.5M $99K +$999K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$2.5M $99K -$3.79M -97.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.28M $137K -$128K -48.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.41M -$1.84M -$2.02M -1110% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $3.43M -$900K -$1.1M -546% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $4.53M $3.89M +$3.79M +3824% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $748K $265K +$132K +99.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $616K $182K -$261K -58.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $877K $202K +$63K +45.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $814K $99K -$28K -22% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $842K $133K -$34K -20.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $876K $443K +$406K +1097% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $470K $139K +$47K +51.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $423K $127K -$37K -22.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $460K $167K -$46K -21.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $506K $37K +$1.18M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$677K $92K -$156K -62.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$521K $164K -$31K -15.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$490K $213K +$22K +11.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$512K -$1.15M -$2.78M -170% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $2.27M $248K +$55K +28.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $2.21M $195K -$10K -4.88% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $2.22M $191K -$21K -9.91% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 $2.25M $1.64M +$1.67M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-01
Q3 2013 $577K $193K -$29K -13.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $606K $205K +$112K +120% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $494K $212K +$88K +71% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $406K -$33K -$751K -105% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $1.16M $222K +$130K +141% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $1.03M $93K +$33K +55% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $994K $124K -$24K -16.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $1.02M $718K +$454K +172% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 $564K $92K -$186K -66.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $750K $60K +$29K +93.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $721K $148K -$160K -51.9% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $881K $264K Oct 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 $278K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $31K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $308K Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.